Does my patient have chronic chagas disease? Development and temporal validation of a diagnostic risk score

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 49, Issue 3, 2016, Pages 329-340

  Do Brasil, Pedro Emmanuel Alvarenga Americano ^a   Xavier, Sergio Salles ^a   Holanda, Marcelo Teixeira ^a   Hasslocher Moreno, Alejandro Marcel ^a   Braga, José Ueleres ^b  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chagas disease; Diagnosis; Nomograms; Sensitivity and specificity; Signs and symptoms

Indexed keywords

ADULT; AGED; ARTICLE; ATRIAL FIBRILLATION; ATRIOVENTRICULAR BLOCK; BEDBUG BITE; BLOOD TRANSFUSION; CARDIOMEGALY; CHAGAS DISEASE; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRASYSTOLE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NOMOGRAM; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SINUS BRADYCARDIA; VALIDATION PROCESS; ADOLESCENT; CHILD; CHRONIC DISEASE; INFANT; NEWBORN; PRESCHOOL CHILD; RISK ASSESSMENT; STATISTICAL MODEL; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK ADJUSTMENT; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84976606708     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/0037-8682-0196-2016     Document Type: Article

References (35)

1. Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 2009; 104 (Suppl 1):17-30.
2. Andrade JP, Marin Neto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas’ heart disease. Arq Bras Cardiol 2011; 97 (Suppl 3):1-48.
3. Tanowitz HB, Weiss LM, Montgomery SP. Chagas disease Has Now Gone Global. PLoS Negl Trop Dis 2011; 5:e1136.
4. Savioli L, Daumerie D. First WHO report on neglected tropical diseases 2010: working to overcome the global impact of neglected tropical diseases. World Health Organization; 2008.
5. Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis 2013; 13:342-348.
6. Secretaria de Vigilância em Saúde, Ministério da Saúde. Consenso Brasileiro em Doença de Chagas. Rev Soc Bras Med Trop 2005; 38 (Suppl 3):7-29.
7. Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 2007; 298:2171-2181.
8. Ministério de la Salud Publica y Assitencia Social. El Salvador. Norma Técnica de Prevención y Control de la Enfermedad de Chagas. San Salvador; 2007.
9. Comité de Parasitología. Guías clinicas de la enfermedad de Chagas. 2006. Parte V. Diagnóstico de laboratorio. Rev Chil Infectol 2008; 25:379-383.
10. Albajar P, Aparicio P, Canavate C, Castro E, Coll O, Coura JR, et al. Diagnosis and treatment of imported Chagas disease. Med Clin (Barc) 2005; 6:230-235.
11. Pérez-Molina J, Rodríguez-Guardado A, Soriano A, Pinazo M-J, Carrilero B, García-Rodríguez M, et al. Guidelines on the treatment of chronic coinfection by Trypanosoma cruzi and HIV outside endemic areas. HIV Clin Trials 2011; 12:287-298.
12. Organización Panamericana de la Salud. OPS/MSF Regional Consultation Technique on Organization and Structure of the Medical Attention of patient with Chagas disease. Rev Soc Bras Med Trop 2005; 38:538-541.
13. Ministerio del Poder Popular para la Salud. Guía para el Diagnóstico, Atención y Manejo Clínico de la Enfermedad de Chagas en Venezuela. Maracay, Estado Aragua, Venezuela; 2014.
14. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
15. Ribeiro ALP, Rocha MOC. Forma indeterminada da doença de Chagas: considerações acerca do diagnóstico e do prognóstico. Rev Soc Bras Med Trop 1998; 31:301-314.
16. Haynes RB, You JJ. The architecture of diagnostic research. In: Knottnerus JA, Buntinx F, editors. The Evidence Based of Clinical Diagnosis - Theory and methods of diagnostic research, vol. 2. BMJ Books; 2009.
17. van Buuren S, Groothuis-Oudshoorn K. Mice: Multivariate Imputation by Chained Equations in R. J Stat Soft 2011; 45:1-67.
18. Greiner M, Sohr D, Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 1995; 185:123-132.
19. Vickers A, Cronin A, Elkin E, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak 2008; 8:533.
20. Nattino G, Finazzi S, Bertolini G. A new calibration test and a reappraisal of the calibration belt for the assessment of prediction models based on dichotomous outcomes. Statist Med 2014; 33:2390-2407.
21. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: the R Foundation for Statistical Computing; 2011. Available online at http://www.Rproject.org/.
22. Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, et al. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas’ disease, in US blood donors. J Infect Dis 1997; 176:1047-1052.
23. Furuchó CR, Umezawa ES, Almeida I, Freitas VL, Bezerra R, Nunes EV, et al. Inconclusive results in conventional serological screening for Chagas’ disease in blood banks: evaluation of cellular and humoral response. Trop Med Int Health 2008; 13:1527-1533.
24. Vinelli E, Aguilar M, Pavón L, Enamorado N. El interrogatorio como instrumento para la exclusión de donantes de sangre con riesgo para la transmisión del Trypanosoma cruzi. Rev Med Hondur 1995; 63:96-99.
25. Hamerschlak N, Pasternak J, Amato Neto V, Carvalho MB, Guerra CS, Coscina AL, et al. Chagas’ disease: an algorithm for donor screening and positive donor counseling. Rev Soc Bras Med Trop 1997; 30:205-209.
26. Pereira GA, Louzada-Neto F, Barbosa VF, Ferreira-Silva MM, de Moraes-Souza H. Performance of six diagnostic tests to screen for Chagas disease in blood banks andprevalence of Trypanosoma cruzi infection among donors with inconclusive serologys creening based on the analysis of epidemiological variables. Rev Bras Hematol Hemoter 2012; 34:292-297.
27. Salles NA, Sabino EC, Cliquet MG, Eluf-Neto J, Mayer A, Almeida-Neto C, et al. Risk of exposure to Chagas’ disease among seroreactive Brazilian blood donors. Transfusion 1996; 36: 969-973.
28. Cucunubá ZM, Flórez AC, Cárdenas A, Pavía P, Montilla M, Aldana R, et al. Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia. Am J Trop Med Hyg 2012; 87:837-842.
29. Avila Arzanegui O, Liendo Arenaza P, Martinez Indart L, Martinez Astorkiza T, Pocheville Guruceta MI, Egurbide Arberas MV. Prevalence of Trypanosoma cruzi infection and vertical transmission in Latin-American pregnant women in a health area of Biscay. Enferm Infecc Microbiol Clin 2013; 31:210-216.
30. Martelli CMT, Andrade ALSS, Silva SA, Zicker F. Risk factors for Trypanosoma cruzi infection among blood donors in Central Brazil. Mem Inst Oswaldo Cruz 1992; 87:339-343.
31. Pirard M, Iihoshi N, Boelaert M, Basanta P, Lopez F, Van der Stuyft P. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005; 45:554.
32. Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, et al. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion 2012; 52:1901-1911.
33. Boggio G. Modelo de regresión logística aplicado a un estudio sobre enfermedad de Chagas. Cad Saude Publica 1997; 13:389-396.
34. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 1st edition. Springer; 2008.
35. Guyatt G, Rennie D, Meade M, Cook D. Users’ Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice, Second Edition. 2nd edition. McGraw-Hill Professional; 2008.